Viewing nowCombinationAltjet Tablet 10/40 mg
Ezetimibe 10mg · Atorvastatin Calcium Trihydrate 43.4mg
Tablet · Prescription medication · Combination
Youngil Pharmaceutical Co., Ltd.

MFDS item code 202101599 · Approved 2021.02.18
This product's status changed to Expired on 2026.02.18. It may no longer be sold, so consult a doctor or pharmacist before taking it.
Improvement of hypercholesterolemia (primary and homozygous familial) and mixed dyslipidemia
This medication helps lower total cholesterol and bad cholesterol, such as LDL-cholesterol, in patients with primary hypercholesterolemia, especially familial and non-familial patients, while increasing good cholesterol, HDL-cholesterol. It can also be used safely and effectively in patients at high risk of atherosclerotic vascular disease due to hypercholesterolemia. For patients with homozygous familial hypercholesterolemia, it can be used in conjunction with or as an alternative to other lipid-lowering therapies. This medication is recommended to be used in conjunction with an appropriate diet, and when diet alone is not sufficient, it is used as an adjunct. It is also important to identify and treat secondary causes such as diabetes and hypothyroidism before use. In summary, this medication is used to effectively manage cardiovascular health by improving dyslipidemia.
This medicine is administered once daily, with or without food. Patients must continue a standard cholesterol-lowering diet before and during treatment with this medicine. The dose of this medicine should be adjusted according to the patient's baseline LDL cholesterol level, recommended treatment goal, and response. Primary hypercholesterolemia The dosage range for this medicine is 10/10mg∼10/80mg once daily. The recommended initial dosage is 10/10mg or 10/20mg once daily. For patients requiring a greater reduction in LDL cholesterol (55% or more), the recommended initial dosage is 10/40mg once daily. After starting treatment with this medicine or adjusting the dose, check blood lipid levels at intervals of 2 weeks or more and adjust the dose accordingly. Homozygous familial hypercholesterolemia The recommended dosage for patients with homozygous familial hypercholesterolemia is 10/40mg or 10/80mg once daily. This medicine is administered as an adjunct to other lipid-lowering therapies (e.g., LDL-Apheresis) or when other lipid-lowering therapies are not useful.
This medication has been reported to cause a rare side effect of rhabdomyolysis, which can lead to serious muscle damage. Therefore, if severe muscle pain or weakness occurs, it is essential to inform a doctor immediately. In cases of serious infections, hypotension, major surgery or trauma, or metabolic disorders, the medication should be discontinued or temporarily halted. It should not be taken if there is an allergy to the active ingredient or any components, if liver function is severely impaired, or if there are persistent unexplained elevations in liver enzymes. Patients with muscle diseases, pregnant or nursing women, and those taking certain antiviral medications should also refrain from using this medication. Patients at high risk of myopathy, such as those with a history of alcohol abuse or liver disease, those with poor kidney function, hypothyroidism, and the elderly should use this medication with caution. This medication may cause side effects such as muscle pain, abdominal pain, and elevated liver enzymes, so if unusual symptoms arise, consultation with a doctor is advised. Liver function tests should be conducted before starting and regularly during treatment, and if signs of liver damage appear, the medication should be discontinued. This medication should not be administered to pregnant or nursing women, and women of childbearing potential should use appropriate contraception while taking this medication. Its safety and efficacy have not been established in children, so it is not recommended for use in pediatric patients. Caution is required for the elderly due to the high risk of myopathy, but no separate dosage adjustment is necessary. There may be interactions with other medications during treatment, so any other medications being taken should be reported to a doctor or pharmacist. In case of overdose, there is no specific antidote, so symptomatic treatment and supportive therapy should be provided while monitoring liver function and muscle enzyme levels. Keep out of reach of children and do not transfer to other containers. Caution is advised while driving or operating machinery as dizziness may occur.
Acute renal failure due to myoglobinuria, rhabdomyolysis, myalgia, abdominal pain, elevated liver enzymes, increased ALT, increased AST, musculoskeletal pain, dizziness, cough, nausea, arthralgia, muscle weakness, hyperkalemia, bronchitis, sinusitis, flushing, intracranial aneurysm, restless legs syndrome, depression, bronchiolitis, dental abscess, vestibular neuritis, bradycardia, hypotension, anemia, hernia, vitamin D deficiency, gastric polyp, duodenal polyp, duodenitis, jaundice, erectile dysfunction, breast mass, skin mass, ingrown toenail, thyroid adenoma, weakness, lethargy, chest pain, peripheral edema, fatigue, fever, rhinitis, hyperglycemia, hypoglycemia, weight gain, loss of appetite, constipation, abdominal bloating, dyspepsia, diarrhea, vomiting, belching, pancreatitis, pharyngeal and laryngeal pain, nosebleed, insomnia, nightmares, headache, altered perception, sensory loss, altered taste, memory loss, peripheral neuropathy, muscle cramps, joint swelling, back pain, neck pain, muscle fatigue, complications from rupture, myopathy, myositis, tendon disorders, muscle rupture, lupus-like syndrome, immune-mediated necrotizing myopathy, thrombocytopenia, allergic reaction, anaphylaxis, hepatitis, cholestasis, hepatic failure, blurred vision, visual impairment, tinnitus, hearing loss, urticaria, skin rash, itching, hair loss, angioedema, polycyclic erythema, Stevens-Johnson syndrome, toxic epidermal necrolysis, gynecomastia, increased serum creatine kinase, positive urinary leukocytes, nightmares, vomiting, abdominal abnormalities, hepatitis, cholelithiasis, cholecystitis, drug-induced liver injury, eosinophilia with systemic symptoms associated with drug reactions, severe cutaneous adverse reactions including polymorphic erythema, fatigue, chest discomfort, edema, asthenia, systemic edema, diabetic neuropathy, tremors, epigastric pain, gastritis, xerostomia, epigastric discomfort, gastrointestinal disturbances, gastroesophageal reflux disease, tongue disorders, palpitations, congestive heart failure, myocardial ischemia, limb pain, frequent urination, cystitis, hematuria, dysuria, nephrolithiasis, nocturia, epididymitis, breast fibrocystic disease, vaginal bleeding, albuminuria, breast enlargement, cervical discharge, nephritis, urinary incontinence, urinary retention, urgency, abnormal ejaculation, uterine bleeding, discoloration of urine, hypoglycemia, increased appetite, vascular neuropathic edema, chest pain, angina, facial edema, fever, neck stiffness, generalized edema, amblyopia, dry eye, refractive aberration, ocular hemorrhage, hearing loss, glaucoma, stereopsis, loss of taste, taste distortion, leukopenia, decreased testosterone, increased cholinesterase, elevated TSH, elevated ACTH, decreased aldosterone, cerebral infarction, palpitations, tachycardia, increased serum creatinine, elevated blood pressure, increased blood urea, increased CPK, abnormal liver function tests
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a sealed container to protect it from air and moisture. It is advisable to maintain the storage temperature between 1 and 30 degrees Celsius at room temperature. Proper storage will help maintain the medication's effectiveness and safety for a longer period.
White or whitish oval film-coated tablet
30 tablets/box [(10 tablets/Alu-Alu x 3)]
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowCombinationEzetimibe 10mg · Atorvastatin Calcium Trihydrate 43.4mg
Tablet · Prescription medication · Combination
Youngil Pharmaceutical Co., Ltd.
CombinationEzetimibe 10mg · Atorvastatin Calcium Trihydrate 21.7mg
Tablet · Prescription medication · Combination
Korea Organon Co., Ltd.
CombinationEzetimibe 10mg · Atorvastatin Calcium Trihydrate 43.4mg
Tablet · Prescription medication · Combination
Korea Organon Co., Ltd.
CombinationEzetimibe 10mg · Atorvastatin Calcium Trihydrate 86.8mg
Tablet · Prescription medication · Combination
Korea Organon Co., Ltd.
CombinationEzetimibe 10mg · Atorvastatin Calcium Trihydrate 10.9mg
Tablet · Prescription medication · Combination
Korea Organon Co., Ltd.
CombinationAtorvastatin Calcium 10.85mg · Ezetimibe 10mg
Tablet · Prescription medication · Combination
Korea HuTex Pharmaceutical Co., Ltd.
CombinationAtorvastatin Calcium 21.7mg · Ezetimibe 10mg
Tablet · Prescription medication · Combination
Korea HuTex Pharmaceutical Co., Ltd.
CombinationAtorvastatin Calcium 43.4mg · Ezetimibe 10mg
Tablet · Prescription medication · Combination
Korea HuTex Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.